Reps. David McKinley (R-WV) and Mike Thompson (D-CA) last night introduced H.R. 4392, a bill that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B Drug Pricing Program. The Centers for Medicare & Medicaid Services recently released a final rule that reduces by nearly 30%, or $1.6 billion, Medicare payments to certain public and non-profit hospitals for outpatient drugs purchased under the 340B program. “The AHA thanks Representatives McKinley and Thompson for leading this bipartisan effort to protect patient care by preventing CMS from reducing Medicare Part B payments for some 340B hospitals,” said AHA Executive Vice President Tom Nickels. “For 25 years, the 340B program has been critical in helping hospitals expand access to lifesaving prescription drugs and comprehensive health care to low-income patients and other vulnerable populations in communities across the country.” The AHA, joined by the Association of American Medical Colleges and America's Essential Hospitals, Nov. 13 filed a federal lawsuit to prevent CMS from implementing these cuts.

Related News Articles

Headline
The Medicare Payment Advisory Commission March 15 released its March report to Congress, which includes its recent recommendations for hospital and other…
Headline
A March 14 editorial in the Washington Post calling for Congress to enact so-called site-neutral policies is “deeply flawed and incredibly out of touch with…
Blog
A March 14 editorial in the Washington Post calling for Congress to enact so-called site-neutral policies is deeply flawed and incredibly out of touch…
Blog
The Medicare Payment Advisory Commission (MedPAC) today released its annual March Report advising Congress on the Medicare fee-for-service (FFS) payment…
Headline
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues…
Headline
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by…